Bausch Health Earnings Estimate

BHC Stock  USD 7.70  0.53  7.39%   
The next projected EPS of Bausch Health is estimated to be 0.8216 with future projections ranging from a low of 0.76 to a high of 1.06. Bausch Health's most recent 12-month trailing earnings per share (EPS TTM) is at -0.13. Please be aware that the consensus of earnings estimates for Bausch Health Companies is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Bausch Health is projected to generate 0.8216 in earnings per share on the 31st of March 2025. Bausch Health earnings estimates show analyst consensus about projected Bausch Health Companies EPS (Earning Per Share). It derives the highest and the lowest estimates based on Bausch Health's historical volatility. Many public companies, such as Bausch Health, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Bausch Health Revenue Breakdown by Earning Segment

By analyzing Bausch Health's earnings estimates, investors can diagnose different trends across Bausch Health's analyst sentiment over time as well as compare current estimates against different timeframes. At present, Bausch Health's Operating Profit Margin is projected to increase slightly based on the last few years of reporting. The current year's Gross Profit Margin is expected to grow to 0.81, whereas Pretax Profit Margin is forecasted to decline to 0.02.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Bausch Health Earnings Estimation Breakdown

The calculation of Bausch Health's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Bausch Health is estimated to be 0.8216 with the future projection ranging from a low of 0.76 to a high of 1.06. Please be aware that this consensus of annual earnings estimates for Bausch Health Companies is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
1.16
0.76
Lowest
Expected EPS
0.8216
1.06
Highest

Bausch Health Earnings Projection Consensus

Suppose the current estimates of Bausch Health's value are higher than the current market price of the Bausch Health stock. In this case, investors may conclude that Bausch Health is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Bausch Health's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2025Current EPS (TTM)
682.71%
1.16
0.8216
-0.13

Bausch Health Earnings History

Earnings estimate consensus by Bausch Health Companies analysts from Wall Street is used by the market to judge Bausch Health's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Bausch Health's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

Bausch Health Quarterly Gross Profit

1.83 Billion

The current year's Price Earnings To Growth Ratio is expected to grow to 0.40, whereas Retained Earnings are projected to grow to (9.3 B). As of February 26, 2025, Common Stock Shares Outstanding is expected to decline to about 251.3 M. In addition to that, Net Loss is expected to decline to about (212.6 M).
Hype
Prediction
LowEstimatedHigh
4.077.1810.29
Details
Intrinsic
Valuation
LowRealHigh
4.687.7910.90
Details
Naive
Forecast
LowNextHigh
4.867.9711.07
Details
6 Analysts
Consensus
LowTargetHigh
8.659.5010.55
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bausch Health. Your research has to be compared to or analyzed against Bausch Health's peers to derive any actionable benefits. When done correctly, Bausch Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Bausch Health Companies. Note that many institutional investors and large investment bankers can move markets due to the volume of Bausch assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Bausch Health. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Bausch Health's stock price in the short term.

Bausch Health Earnings per Share Projection vs Actual

Actual Earning per Share of Bausch Health refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Bausch Health Companies predict the company's earnings will be in the future. The higher the earnings per share of Bausch Health, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Bausch Health Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Bausch Health, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Bausch Health should always be considered in relation to other companies to make a more educated investment decision.

Bausch Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Bausch Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-02-20
2024-12-311.12671.160.0333
2024-10-30
2024-09-301.021.130.1110 
2024-08-01
2024-06-300.880.027-0.85396 
2024-05-02
2024-03-310.720.6-0.1216 
2024-02-22
2023-12-311.021.150.1312 
2023-11-02
2023-09-300.921.020.110 
2023-08-03
2023-06-300.780.820.04
2023-05-04
2023-03-310.720.52-0.227 
2023-02-23
2022-12-310.911.030.1213 
2022-11-03
2022-09-300.840.76-0.08
2022-08-09
2022-06-300.890.56-0.3337 
2022-05-10
2022-03-311.030.73-0.329 
2022-02-23
2021-12-311.121.280.1614 
2021-11-02
2021-09-301.041.160.1211 
2021-08-03
2021-06-300.950.970.02
2021-05-04
2021-03-310.941.040.110 
2021-02-24
2020-12-311.121.330.2118 
2020-11-03
2020-09-301.041.320.2826 
2020-08-06
2020-06-300.660.46-0.230 
2020-05-07
2020-03-310.880.880.0
2020-02-19
2019-12-311.151.12-0.03
2019-11-04
2019-09-301.091.190.1
2019-08-06
2019-06-301.041.040.0
2019-05-06
2019-03-310.861.020.1618 
2019-02-20
2018-12-310.841.030.1922 
2018-11-06
2018-09-300.841.130.2934 
2018-08-07
2018-06-300.80.930.1316 
2018-05-08
2018-03-310.60.880.2846 
2018-02-28
2017-12-310.970.980.01
2017-11-07
2017-09-300.891.040.1516 
2017-08-08
2017-06-300.941.030.09
2017-05-09
2017-03-310.870.78-0.0910 
2017-02-28
2016-12-311.21.260.06
2016-11-08
2016-09-301.751.55-0.211 
2016-08-09
2016-06-301.471.4-0.07
2016-06-07
2016-03-311.371.27-0.1
2016-03-15
2015-12-312.612.5-0.11
2015-10-19
2015-09-302.72.740.04
2015-07-23
2015-06-302.462.560.1
2015-04-29
2015-03-312.342.360.02
2015-02-22
2014-12-312.552.580.03
2014-10-20
2014-09-301.992.110.12
2014-07-31
2014-06-301.91.910.01
2014-05-08
2014-03-311.721.760.04
2014-02-27
2013-12-312.062.150.09
2013-10-31
2013-09-301.411.430.02
2013-08-07
2013-06-301.281.340.06
2013-05-02
2013-03-311.251.30.05
2013-02-28
2012-12-311.21.220.02
2012-11-02
2012-09-301.121.150.03
2012-08-02
2012-06-300.991.010.02
2012-05-03
2012-03-310.960.990.03
2012-02-27
2011-12-310.850.940.0910 
2011-11-03
2011-09-300.570.660.0915 
2011-08-04
2011-06-300.660.730.0710 
2011-05-09
2011-03-310.510.620.1121 
2011-02-24
2010-12-310.450.510.0613 
2010-11-04
2010-09-300.480.44-0.04
2010-08-05
2010-06-300.260.60.34130 
2010-05-06
2010-03-310.270.590.32118 
2010-02-25
2009-12-310.370.560.1951 
2009-11-05
2009-09-300.40.32-0.0820 
2009-08-06
2009-06-300.340.340.0
2009-05-06
2009-03-310.30.28-0.02
2009-02-26
2008-12-310.320.340.02
2008-11-06
2008-09-300.290.360.0724 
2008-08-13
2008-06-300.340.370.03
2008-05-08
2008-03-310.390.38-0.01
2008-03-13
2007-12-310.390.450.0615 
2007-11-08
2007-09-300.40.420.02
2007-08-08
2007-06-300.370.40.03
2007-05-10
2007-03-310.380.580.252 
2007-03-15
2006-12-310.770.930.1620 
2006-11-09
2006-09-300.650.830.1827 
2006-08-10
2006-06-300.460.50.04
2006-05-11
2006-03-310.370.430.0616 
2006-03-23
2005-12-310.740.770.03
2005-11-11
2005-09-300.60.690.0915 
2005-08-04
2005-06-300.260.340.0830 
2005-05-05
2005-03-310.070.070.0
2005-03-10
2004-12-310.50.580.0816 
2004-11-04
2004-09-300.370.31-0.0616 
2004-08-04
2004-06-300.240.280.0416 
2004-04-29
2004-03-310.130.180.0538 
2004-03-03
2003-12-310.280.280.0
2003-10-30
2003-09-300.390.22-0.1743 
2003-07-29
2003-06-300.470.520.0510 
2003-04-29
2003-03-310.380.390.01
2003-03-04
2002-12-310.570.60.03
2002-10-29
2002-09-300.460.470.01
2002-07-25
2002-06-300.380.390.01
2002-04-25
2002-03-310.30.320.02
2002-02-21
2001-12-310.430.460.03
2001-10-29
2001-09-300.360.370.01
2001-08-01
2001-06-300.250.30.0520 
2001-04-26
2001-03-310.180.20.0211 
2001-02-28
2000-12-310.260.280.02
2000-10-27
2000-09-300.250.270.02
2000-08-02
2000-06-300.160.170.01
2000-04-28
2000-03-310.10.10.0
2000-02-24
1999-12-310.190.20.01
1999-10-28
1999-09-300.170.180.01
1999-07-28
1999-06-300.120.120.0
1999-04-29
1999-03-310.090.090.0
1999-02-26
1998-12-310.130.140.01
1998-11-27
1998-09-300.120.120.0
1998-07-28
1998-06-300.090.090.0
1998-04-29
1998-03-310.070.070.0
1998-02-25
1997-12-310.080.130.0562 
1997-07-24
1997-06-300.070.070.0
1997-04-28
1997-03-310.060.060.0
1997-02-27
1996-12-310.060.070.0116 
1996-10-29
1996-09-300.060.060.0
1996-07-17
1996-06-300.040.060.0250 
1996-04-17
1996-03-310.030.050.0266 

About Bausch Health Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Bausch Health earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Bausch Health estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Bausch Health fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-9.8 B-9.3 B
Retained Earnings Total Equity-8.3 B-7.9 B
Earnings Yield(0.02)(0.02)
Price Earnings Ratio(64.48)(61.26)
Price Earnings To Growth Ratio 0.38  0.40 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.61)
Earnings Share
(0.13)
Revenue Per Share
26.155
Quarterly Revenue Growth
0.063
Return On Assets
0.0433
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.